DSpace at RU >

Browsing by Author Girardin, S.E.

Full Text	Issue Date	Title	Author(s)
	2011	Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2	Plantinga, T.S.; Crisan, T.O.; Oosting, M.; Veerdonk, F.L. van de; Jong, D.J. de, et al
	2008	Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis.	Joosten, L.A.B.; Heinhuis, B.; Abdollahi-Roodsaz, S.; Ferwerda, G.; Lebourhis, L., et al
	2008	Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.	Ferwerda, G.; Kramer, M.; Jong, D. de; Piccini, A.; Joosten, L.A.B., et al
	2007	Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.	Ferwerda, G.; Kullberg, B.J.; Jong, D.J. de; Girardin, S.E.; Langenberg, D.M., et al
	2006	Normal responses to specific NOD1 ligands.	Ferwerda, G.; Girardin, S.E.; Meer, J.W.M. van der; Netea, M.G.
	2006	Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans.	Graaf, C.A.A. van der; Netea, M.G.; Franke, B.; Girardin, S.E.; Meer, J.W.M. van der, et al
	2006	Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.	Netea, M.G.; Azam, T.; Ferwerda, G.; Girardin, S.E.; Kim, S.H., et al
	2005	NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis	Ferwerda, G.; Girardin, S.E.; Kullberg, B.J.; Bourhis, L. Le; Jong, D.J. de, et al
	2005	NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.	Netea, M.G.; Ferwerda, G.; Jong, D.J. de; Girardin, S.E.; Kullberg, B.J., et al
	2005	Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.	Netea, M.G.; Ferwerda, G.; Jong, D.J. de; Jansen, T.; Jacobs, L., et al
	2005	IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.	Netea, M.G.; Azam, T.; Ferwerda, G.; Girardin, S.E.; Walsh, M., et al
	2005	The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.	Netea, M.G.; Ferwerda, G.; Jong, D.J. de; Werts, C.; Boneca, I.G., et al